PTLF — Petlife Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.02m
- $0.82m
Annual balance sheet for Petlife Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
C2013 August 31st | 2014 August 31st | 2015 August 31st | 2016 August 31st | 2017 August 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0 | 0.007 | 0 | 0.001 | 0.054 |
Net Total Receivables | 0 | 0.011 | 0.005 | 0 | — |
Prepaid Expenses | |||||
Total Current Assets | 0 | 0.017 | 0.005 | 0.001 | 0.055 |
Net Intangible Assets | |||||
Total Assets | 0 | 0.017 | 0.005 | 0.001 | 0.055 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0 | 0 | 0.371 | 3.24 | 1.44 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0 | 0 | 0.371 | 3.24 | 1.44 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0 | 0.017 | -0.365 | -3.23 | -1.38 |
Total Liabilities & Shareholders' Equity | 0 | 0.017 | 0.005 | 0.001 | 0.055 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |